IMVT compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

IMVTImmunovant, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IMVT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 6 '26±9.0%▲+1.17%×0.13

May 20 '26±15.6%▲+35.26%×2.26

Feb 6 '26±13.5%▲+12.43%×0.92

Nov 10 '25±16.2%▲+0.09%×0.01

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 4 '26±3.7%▲+3.73%×1.00

Aug 5 '26±4.1%▲+4.57%×1.12

= impliedIMVT realized, solidAMGN realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

May 1 '26

±3.9%

▼−4.75%

×1.23

Feb 4 '26±3.7%▲+8.15%×2.22

IMVTImmunovant, Inc.

30.51▲+7.47%· post 30.00

Mkt cap$6.3BRevenue—Revenue—

AMGNAmgen Inc

460.55▲+0.06%· post 460.42

ClosedNov 6 '26

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

ClosedNov 6 '26

IMVTImmunovant, Inc.

AMGNAmgen Inc

30.51▲+7.47%post 30.00

Price

460.55▲+0.06%post 460.42

$6.3B

Mkt cap

$249.0B

—

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

IMVT30.51▲+7.47%vsAMGN460.55▲+0.06%ClosedNov 6 '26